Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers. Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is used to describe the acute onset of symptomatic hepatitis. Symptoms include changes I appetite, dry mouth, yellowing of skin or eyes, weight loss, fever and fatigue. Sometime alcoholic hepatitis could get serious conditions include fluid buildup in the abdomen, confusion or brain fog and bleeding in esophagus or stomach. Treatment for alcoholic hepatitis involves therapies and drinking cessation to ease the sign and symptoms of liver damage. Corticosteroids are the current main treatment for alcoholic hepatitis in patients who do not have contraindication for steroid treatment. Corticosteroids are the medications have shown short-term benefits in increasing survival of certain people suffer with alcoholic hepatitis. Pentoxifylline is recommend to patients who can’t take corticosteroids. Studies indicate that pentoxifylline might not be effective for people with mild alcoholic hepatitis or people who have not respond to steroid treatment.
The global alcoholic hepatitis therapeutics market is expected to witness a favorable growth during the forecast period. Increasing incidence of liver diseases and high success rate of pipeline drugs are the major factors which increase global alcoholic hepatitis market. Moreover high adoption rate for novel therapeutic products and increasing prevalence of alcoholic liver disease are some other factors that are expected to fuel the demand of global alcoholic hepatitis market. Global alcoholic hepatitis market shows potential to be expanding and lucrative field due to increasing merger and acquisitions among pharmaceutical companies to develop advance therapies for treating liver diseases. Furthermore, increased focus on retaining best quality of life is one the factor contributing to the growth of the market. However increasing health care expenditure, stringent reimbursement policies and high development cost are some factors that might hinder the growth of alcoholic hepatitis therapeutics market in forecast period.
Market Analysis and Insights: Global Alcoholic Hepatitis Therapeutic Market
The global Alcoholic Hepatitis Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Alcoholic Hepatitis Therapeutic Scope and Market Size
Alcoholic Hepatitis Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alcoholic Hepatitis Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Alkermes
Conatus pharmaceuticals
Dainippon sumitomo pharma
Generon corporation
Immuron limited
Lupin Laboratories
Intercept Pharmaceuticals
Teva Pharmaceuticals
Sanofi-Aventis
Alcoholic Hepatitis Therapeutic Breakdown Data by Type
Monoclonal Antibodies
Caspase Protease Inhibitor
Corticosteroids
Hemorheologic Agents
Anabolic Steroids
Hepatotropic Hormones
Sulfhydryl Agents
Others
Alcoholic Hepatitis Therapeutic Breakdown Data by Application
Hospitals and Clinics
Research and Development
The global alcoholic hepatitis therapeutics market is expected to witness a favorable growth during the forecast period. Increasing incidence of liver diseases and high success rate of pipeline drugs are the major factors which increase global alcoholic hepatitis market. Moreover high adoption rate for novel therapeutic products and increasing prevalence of alcoholic liver disease are some other factors that are expected to fuel the demand of global alcoholic hepatitis market. Global alcoholic hepatitis market shows potential to be expanding and lucrative field due to increasing merger and acquisitions among pharmaceutical companies to develop advance therapies for treating liver diseases. Furthermore, increased focus on retaining best quality of life is one the factor contributing to the growth of the market. However increasing health care expenditure, stringent reimbursement policies and high development cost are some factors that might hinder the growth of alcoholic hepatitis therapeutics market in forecast period.
Market Analysis and Insights: Global Alcoholic Hepatitis Therapeutic Market
The global Alcoholic Hepatitis Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Alcoholic Hepatitis Therapeutic Scope and Market Size
Alcoholic Hepatitis Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alcoholic Hepatitis Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Alkermes
Conatus pharmaceuticals
Dainippon sumitomo pharma
Generon corporation
Immuron limited
Lupin Laboratories
Intercept Pharmaceuticals
Teva Pharmaceuticals
Sanofi-Aventis
Alcoholic Hepatitis Therapeutic Breakdown Data by Type
Monoclonal Antibodies
Caspase Protease Inhibitor
Corticosteroids
Hemorheologic Agents
Anabolic Steroids
Hepatotropic Hormones
Sulfhydryl Agents
Others
Alcoholic Hepatitis Therapeutic Breakdown Data by Application
Hospitals and Clinics
Research and Development
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Alcoholic Hepatitis Therapeutic Revenue
1.4 Market by Type
1.4.1 Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies
1.4.3 Caspase Protease Inhibitor
1.4.4 Corticosteroids
1.4.5 Hemorheologic Agents
1.4.6 Anabolic Steroids
1.4.7 Hepatotropic Hormones
1.4.8 Sulfhydryl Agents
1.4.9 Others
1.5 Market by Application
1.5.1 Global Alcoholic Hepatitis Therapeutic Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Research and Development
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Alcoholic Hepatitis Therapeutic Market Perspective (2015-2026)
2.2 Global Alcoholic Hepatitis Therapeutic Growth Trends by Regions
2.2.1 Alcoholic Hepatitis Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Alcoholic Hepatitis Therapeutic Historic Market Share by Regions (2015-2020)
2.2.3 Alcoholic Hepatitis Therapeutic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Alcoholic Hepatitis Therapeutic Market Growth Strategy
2.3.6 Primary Interviews with Key Alcoholic Hepatitis Therapeutic Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Alcoholic Hepatitis Therapeutic Players by Market Size
3.1.1 Global Top Alcoholic Hepatitis Therapeutic Players by Revenue (2015-2020)
3.1.2 Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Players (2015-2020)
3.1.3 Global Alcoholic Hepatitis Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Alcoholic Hepatitis Therapeutic Market Concentration Ratio
3.2.1 Global Alcoholic Hepatitis Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Alcoholic Hepatitis Therapeutic Revenue in 2019
3.3 Alcoholic Hepatitis Therapeutic Key Players Head office and Area Served
3.4 Key Players Alcoholic Hepatitis Therapeutic Product Solution and Service
3.5 Date of Enter into Alcoholic Hepatitis Therapeutic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Alcoholic Hepatitis Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
5.2 Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
6.2 Alcoholic Hepatitis Therapeutic Key Players in North America (2019-2020)
6.3 North America Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
6.4 North America Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
7 Europe
7.1 Europe Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
7.2 Alcoholic Hepatitis Therapeutic Key Players in Europe (2019-2020)
7.3 Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
7.4 Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
8 China
8.1 China Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
8.2 Alcoholic Hepatitis Therapeutic Key Players in China (2019-2020)
8.3 China Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
8.4 China Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
9 Japan
9.1 Japan Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
9.2 Alcoholic Hepatitis Therapeutic Key Players in Japan (2019-2020)
9.3 Japan Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
9.4 Japan Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
10.2 Alcoholic Hepatitis Therapeutic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
10.4 Southeast Asia Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
11 India
11.1 India Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
11.2 Alcoholic Hepatitis Therapeutic Key Players in India (2019-2020)
11.3 India Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
11.4 India Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
12.2 Alcoholic Hepatitis Therapeutic Key Players in Central & South America (2019-2020)
12.3 Central & South America Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
12.4 Central & South America Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Alkermes
13.1.1 Alkermes Company Details
13.1.2 Alkermes Business Overview
13.1.3 Alkermes Alcoholic Hepatitis Therapeutic Introduction
13.1.4 Alkermes Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020))
13.1.5 Alkermes Recent Development
13.2 Conatus pharmaceuticals
13.2.1 Conatus pharmaceuticals Company Details
13.2.2 Conatus pharmaceuticals Business Overview
13.2.3 Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Introduction
13.2.4 Conatus pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.2.5 Conatus pharmaceuticals Recent Development
13.3 Dainippon sumitomo pharma
13.3.1 Dainippon sumitomo pharma Company Details
13.3.2 Dainippon sumitomo pharma Business Overview
13.3.3 Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Introduction
13.3.4 Dainippon sumitomo pharma Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.3.5 Dainippon sumitomo pharma Recent Development
13.4 Generon corporation
13.4.1 Generon corporation Company Details
13.4.2 Generon corporation Business Overview
13.4.3 Generon corporation Alcoholic Hepatitis Therapeutic Introduction
13.4.4 Generon corporation Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.4.5 Generon corporation Recent Development
13.5 Immuron limited
13.5.1 Immuron limited Company Details
13.5.2 Immuron limited Business Overview
13.5.3 Immuron limited Alcoholic Hepatitis Therapeutic Introduction
13.5.4 Immuron limited Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.5.5 Immuron limited Recent Development
13.6 Lupin Laboratories
13.6.1 Lupin Laboratories Company Details
13.6.2 Lupin Laboratories Business Overview
13.6.3 Lupin Laboratories Alcoholic Hepatitis Therapeutic Introduction
13.6.4 Lupin Laboratories Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.6.5 Lupin Laboratories Recent Development
13.7 Intercept Pharmaceuticals
13.7.1 Intercept Pharmaceuticals Company Details
13.7.2 Intercept Pharmaceuticals Business Overview
13.7.3 Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Introduction
13.7.4 Intercept Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.7.5 Intercept Pharmaceuticals Recent Development
13.8 Teva Pharmaceuticals
13.8.1 Teva Pharmaceuticals Company Details
13.8.2 Teva Pharmaceuticals Business Overview
13.8.3 Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Introduction
13.8.4 Teva Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.8.5 Teva Pharmaceuticals Recent Development
13.9 Sanofi-Aventis
13.9.1 Sanofi-Aventis Company Details
13.9.2 Sanofi-Aventis Business Overview
13.9.3 Sanofi-Aventis Alcoholic Hepatitis Therapeutic Introduction
13.9.4 Sanofi-Aventis Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.9.5 Sanofi-Aventis Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Alcoholic Hepatitis Therapeutic Revenue
1.4 Market by Type
1.4.1 Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies
1.4.3 Caspase Protease Inhibitor
1.4.4 Corticosteroids
1.4.5 Hemorheologic Agents
1.4.6 Anabolic Steroids
1.4.7 Hepatotropic Hormones
1.4.8 Sulfhydryl Agents
1.4.9 Others
1.5 Market by Application
1.5.1 Global Alcoholic Hepatitis Therapeutic Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Research and Development
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Alcoholic Hepatitis Therapeutic Market Perspective (2015-2026)
2.2 Global Alcoholic Hepatitis Therapeutic Growth Trends by Regions
2.2.1 Alcoholic Hepatitis Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Alcoholic Hepatitis Therapeutic Historic Market Share by Regions (2015-2020)
2.2.3 Alcoholic Hepatitis Therapeutic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Alcoholic Hepatitis Therapeutic Market Growth Strategy
2.3.6 Primary Interviews with Key Alcoholic Hepatitis Therapeutic Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Alcoholic Hepatitis Therapeutic Players by Market Size
3.1.1 Global Top Alcoholic Hepatitis Therapeutic Players by Revenue (2015-2020)
3.1.2 Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Players (2015-2020)
3.1.3 Global Alcoholic Hepatitis Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Alcoholic Hepatitis Therapeutic Market Concentration Ratio
3.2.1 Global Alcoholic Hepatitis Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Alcoholic Hepatitis Therapeutic Revenue in 2019
3.3 Alcoholic Hepatitis Therapeutic Key Players Head office and Area Served
3.4 Key Players Alcoholic Hepatitis Therapeutic Product Solution and Service
3.5 Date of Enter into Alcoholic Hepatitis Therapeutic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Alcoholic Hepatitis Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
5.2 Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
6.2 Alcoholic Hepatitis Therapeutic Key Players in North America (2019-2020)
6.3 North America Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
6.4 North America Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
7 Europe
7.1 Europe Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
7.2 Alcoholic Hepatitis Therapeutic Key Players in Europe (2019-2020)
7.3 Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
7.4 Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
8 China
8.1 China Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
8.2 Alcoholic Hepatitis Therapeutic Key Players in China (2019-2020)
8.3 China Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
8.4 China Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
9 Japan
9.1 Japan Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
9.2 Alcoholic Hepatitis Therapeutic Key Players in Japan (2019-2020)
9.3 Japan Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
9.4 Japan Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
10.2 Alcoholic Hepatitis Therapeutic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
10.4 Southeast Asia Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
11 India
11.1 India Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
11.2 Alcoholic Hepatitis Therapeutic Key Players in India (2019-2020)
11.3 India Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
11.4 India Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
12.2 Alcoholic Hepatitis Therapeutic Key Players in Central & South America (2019-2020)
12.3 Central & South America Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
12.4 Central & South America Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Alkermes
13.1.1 Alkermes Company Details
13.1.2 Alkermes Business Overview
13.1.3 Alkermes Alcoholic Hepatitis Therapeutic Introduction
13.1.4 Alkermes Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020))
13.1.5 Alkermes Recent Development
13.2 Conatus pharmaceuticals
13.2.1 Conatus pharmaceuticals Company Details
13.2.2 Conatus pharmaceuticals Business Overview
13.2.3 Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Introduction
13.2.4 Conatus pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.2.5 Conatus pharmaceuticals Recent Development
13.3 Dainippon sumitomo pharma
13.3.1 Dainippon sumitomo pharma Company Details
13.3.2 Dainippon sumitomo pharma Business Overview
13.3.3 Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Introduction
13.3.4 Dainippon sumitomo pharma Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.3.5 Dainippon sumitomo pharma Recent Development
13.4 Generon corporation
13.4.1 Generon corporation Company Details
13.4.2 Generon corporation Business Overview
13.4.3 Generon corporation Alcoholic Hepatitis Therapeutic Introduction
13.4.4 Generon corporation Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.4.5 Generon corporation Recent Development
13.5 Immuron limited
13.5.1 Immuron limited Company Details
13.5.2 Immuron limited Business Overview
13.5.3 Immuron limited Alcoholic Hepatitis Therapeutic Introduction
13.5.4 Immuron limited Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.5.5 Immuron limited Recent Development
13.6 Lupin Laboratories
13.6.1 Lupin Laboratories Company Details
13.6.2 Lupin Laboratories Business Overview
13.6.3 Lupin Laboratories Alcoholic Hepatitis Therapeutic Introduction
13.6.4 Lupin Laboratories Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.6.5 Lupin Laboratories Recent Development
13.7 Intercept Pharmaceuticals
13.7.1 Intercept Pharmaceuticals Company Details
13.7.2 Intercept Pharmaceuticals Business Overview
13.7.3 Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Introduction
13.7.4 Intercept Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.7.5 Intercept Pharmaceuticals Recent Development
13.8 Teva Pharmaceuticals
13.8.1 Teva Pharmaceuticals Company Details
13.8.2 Teva Pharmaceuticals Business Overview
13.8.3 Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Introduction
13.8.4 Teva Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.8.5 Teva Pharmaceuticals Recent Development
13.9 Sanofi-Aventis
13.9.1 Sanofi-Aventis Company Details
13.9.2 Sanofi-Aventis Business Overview
13.9.3 Sanofi-Aventis Alcoholic Hepatitis Therapeutic Introduction
13.9.4 Sanofi-Aventis Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.9.5 Sanofi-Aventis Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
